Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001262463-12-000394
Filing Date
2012-10-15
Accepted
2012-10-15 14:18:12
Documents
9
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K plpl_form10k6302012.htm 10-K 494939
2 EXHIBIT 31 ex31.htm EX-31 11126
3 EXHIBIT 32 ex32.htm EX-32 6924
  Complete submission text file 0001262463-12-000394.txt   2420169

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT fil-20120630.xml EX-101.INS 190703
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT fil-20120630.xsd EX-101.SCH 31012
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT fil-20120630_cal.xml EX-101.CAL 43051
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT fil-20120630_def.xml EX-101.DEF 64023
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT fil-20120630_lab.xml EX-101.LAB 176528
9 XBRL TAXONOMY PRESENTATION LINKBASE DOCUMENT fil-20120630_pre.xml EX-101.PRE 135614
Mailing Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102
Business Address 2226 EASTLAKE AVENUE EAST #156 SEATTLE WA 98102 (425) 466-0212
Plandai Biotechnology, Inc. (Filer) CIK: 0001317880 (see all company filings)

EIN.: 453642179 | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-51206 | Film No.: 121143488
SIC: 2834 Pharmaceutical Preparations